Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00374621 · ClinicalTrials.gov registry record · NA
Trial of Cervical Ripening and Labor Induction Using Misoprostol With or Without Intravaginal Isosorbide Mononitrate
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 156
- Enrollment target
NCT00374621: Completed NA study, sponsored by Stanford University.
NCT00374621 is a NA study that has completed, run by Stanford University. The registered enrollment target is 156 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00374621, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 156 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the efficacy and safety of the addition of intravaginal isosorbide mononitrate to an established protocol of oral misoprostol for cervical ripening and labor induction.
Interventions
- DRUG Misoprostol with or without isosorbide mononitrate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 156 participants |
| Start Date | 2006-09 |
| Est. Completion | 2010-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00374621
The ClinicalTrials.gov registry entry for NCT00374621 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 156 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Misoprostol with or without isosorbide mononitrate is the first listed.
NCT00374621 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00374621 about?
NCT00374621 is a clinical study titled "Trial of Cervical Ripening and Labor Induction Using Misoprostol With or Without Intravaginal Isosorbide Mononitrate". The purpose of this study is to determine the efficacy and safety of the addition of intravaginal isosorbide mononitrate to an established protocol of oral misoprostol for cervical ripening and labor induction.
What is the current status of trial NCT00374621?
This trial is currently completed. It is a NA study. The enrollment target is 156 participants. The study started on 2006-09. Estimated completion is 2010-01.
What interventions are being tested in trial NCT00374621?
The interventions under investigation include: Misoprostol with or without isosorbide mononitrate (DRUG).
Who is sponsoring clinical trial NCT00374621?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.